Progestogen deficiency and endometrial cancer risk

Maturitas

Volumn 62, Issue 4, 2009, Pages 334-337

  Schindler, Adolf E ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Endometrial cancer; Endometrial hyperplasia; Progesterone; Progestin; Progestogen

Indexed keywords

CYPROTERONE ACETATE; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; SEX HORMONE BINDING GLOBULIN;

ANOVULATION; CANCER RISK; CLIMACTERIUM; COLON CANCER; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE INFERTILITY; HORMONE DEFICIENCY; HUMAN; HYSTERECTOMY; LUTEAL INSUFFICIENCY; OBESITY; OLIGOMENORRHEA; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; REVIEW;

CLIMACTERIC; CORPUS LUTEUM; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENARCHE; MENSTRUATION DISTURBANCES; OVARIAN DISEASES; OVERWEIGHT; PROGESTINS; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN;

EID: 67349096036     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.12.018     Document Type: Review

References (17)

1. Weiterpass E., Persson I., Adami H.O., et al. Body size in different periods of life, diabetes mellitus, hypertension and risk of postmenopausal and endometrial cancer. Cancer Causes Control 11 (2000) 185-192
2. Sherman Me, Madigan M.P., Lacey J.V., et al. Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones. Gynecol Oncol 107 (2007) 431-435
3. Xu W.H., Xiang Y.B., Ruan Z.X., et al. Menstrual and reproductive factors and endometrial cancer risk: Results from a population-based case-control study in urban Shanghai. Int. J. Cancer 108 (2004) 613-619
4. Wernli K.J., Ray R.M., Gao D.L., De Roos A.J., Checkoway H., and Thoma D.B. Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women. Cancer Causes Control 17 (2006) 949-955
5. Garrett A., and Quinn M.A. Hormonal therapies and gynaecological cancers. Best Practice Res Clin Obstet Gynecol 22 (2008) 407-421
6. Davies S., Dai D., Wolf D.M., and Leslie K.K. Immunomodulatory and transcriptional effects of progesterone through progesterone A and B receptors in Hec50co poorly differentiated endometrial cancer cells. J Soc Gynecol Invest 11 (2004) 494-499
7. Maxwell G.L., Schildkraut J.M., Calingaert B., et al. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk. Gynecol Oncol 103 (2006) 535-540
8. Grady D., Gebretsadik Treatment T., Kerlikowske K., et al. Hormone replacement therapy and endometrial cancer risk: a metaanalysis. Obstet Gynecol 85 (1995) 304-313
9. Lacey J.V., Brinton L.A., Lubin J.H., and Sherman M.E. Endometrial carcinoma risks among menopausal estrogen plus progestogen and unopposed estrogen users in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 14 (2005) 1724-1731
10. Strom B.L., Schinner R., Weber A., et al. Case control study of postmenopausal hormone replacement therapy and endometrial cancer. Am J Epidemiol 164 (2006) 775-786
11. Chuback J., Doherty J.A., Cushing-Hangen K.L., et al. Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy. Cancer Causes Control 18 (2007) 1001-1007
12. Mizunuma H., Honjo H., Aso T., et al. Postmenopausal hormone replacement therapy use and risk of endometrial cancer in Japanese women. Climacteric 4 (2001) 293-298
13. Doherty J.A., Cushing-Hangen K.L., Saltzmann B.S., et al. Long-term use of postmenopausal estrogen and progestin hormonal replacement therapy and the risk of endometrial cancer. Obstet Gynecol 197 (2007) 139
14. Roussouw J.E., Anderson G.U., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy post menopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-331
15. Schindler AE Medikamtentöse Therapie. In: Schindler AE (Ed.), Gutartige Proliferative Erkrankungen der Frau. Bücherei des Frauenarztes, vol. 40. Stuttgart: Enke; 1991. p. 50-86.
16. Lai C.H., and Huang H.J. The role of hormones for the treatment of endometrial hyperplasia and endometrial cancer. Curr Opin Obstet Gynecol 18 (2006) 29-34
17. Schindler A.E. Progestins and endometrial cancer. Gynecol Endocrinol 15 Suppl. 1 (2001) 29-36